Thrivent Financial for Lutherans decreased its position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 9.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 278,869 shares of the technology company’s stock after selling 29,851 shares during the quarter. Thrivent Financial for Lutherans owned about 1.03% of Plexus worth $37,734,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Plexus by 7.5% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,955 shares of the technology company’s stock worth $941,000 after purchasing an additional 484 shares in the last quarter. Capital Fund Management S.A. raised its stake in Plexus by 28.4% during the 2nd quarter. Capital Fund Management S.A. now owns 41,043 shares of the technology company’s stock worth $5,554,000 after buying an additional 9,076 shares during the period. Ritholtz Wealth Management lifted its holdings in Plexus by 109.8% during the second quarter. Ritholtz Wealth Management now owns 4,660 shares of the technology company’s stock worth $631,000 after acquiring an additional 2,439 shares in the last quarter. Acadian Asset Management LLC grew its stake in Plexus by 666.3% in the first quarter. Acadian Asset Management LLC now owns 14,660 shares of the technology company’s stock valued at $1,876,000 after acquiring an additional 12,747 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Plexus in the second quarter worth about $1,969,000. Institutional investors and hedge funds own 94.45% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have recently weighed in on PLXS shares. Stifel Nicolaus set a $150.00 price objective on Plexus in a report on Friday, October 24th. Williams Trading set a $165.00 target price on shares of Plexus in a report on Monday, September 22nd. Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a research report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Plexus presently has a consensus rating of “Hold” and a consensus target price of $159.00.
Insider Activity
In other Plexus news, COO Oliver K. Mihm sold 2,327 shares of the business’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $143.18, for a total transaction of $333,179.86. Following the sale, the chief operating officer directly owned 18,442 shares of the company’s stock, valued at $2,640,525.56. The trade was a 11.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total value of $195,220.71. Following the completion of the transaction, the chief accounting officer owned 21,544 shares of the company’s stock, valued at $3,122,371.92. The trade was a 5.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 13,172 shares of company stock worth $1,883,740. 1.76% of the stock is currently owned by company insiders.
Plexus Trading Down 0.1%
NASDAQ:PLXS opened at $159.72 on Tuesday. The company has a market cap of $4.28 billion, a P/E ratio of 25.51 and a beta of 0.81. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89. The business has a 50 day moving average price of $145.40 and a two-hundred day moving average price of $138.76. The company has a quick ratio of 0.77, a current ratio of 1.58 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.30. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the firm posted $1.85 earnings per share. The firm’s revenue for the quarter was up .7% on a year-over-year basis. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Unassuming Evergy Energy: The AI Boost Your Income Portfolio Needs
- Overbought Stocks Explained: Should You Trade Them?
- Pfizer Adds to Its Big Bet on Weight Loss Drugs
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
